Literature DB >> 23353834

Critical role of TXNIP in oxidative stress, DNA damage and retinal pericyte apoptosis under high glucose: implications for diabetic retinopathy.

Takhellambam S Devi1, Ken-Ichi Hosoya, Tetsuya Terasaki, Lalit P Singh.   

Abstract

Diabetic retinopathy (DR) is characterized by early loss of retinal capillary pericytes and microvascular dysfunction. We recently showed that pro-oxidative stress and pro-apoptotic thioredoxin interacting protein (TXNIP) is significantly up-regulated in rat retinas in experimental diabetes and mediates inflammation and apoptosis. Therefore, we hypothesize here that TXNIP up-regulation in pericyte plays a causative role in oxidative stress and apoptosis under sustained high glucose exposure in culture. We maintained a rat retinal capillary pericyte cell line (TR-rPCT1) for 5 days under low glucose (LG, 5.5mM) or high glucose (HG, 25 mM) with or without anti-oxidant N-acetylcysteine (5mM, NAC), Azaseine (2 μM, AzaS), an inhibitor of TXNIP, and TXNIP siRNA (siTXNIP3, 20 nM). The results show that HG increases TXNIP expression in TR-rPCT1, which correlates positively with ROS generation, protein S-nitrosylation, and pro-apoptotic caspase-3 activation. Furthermore, pericyte apoptosis is demonstrated by DNA fragmentation (alkaline comet assay) and a reduction in MTT survival assay. Treatment of TR-rPCT1 with NAC or an inhibition of TXNIP by AzaS or siTXNIP3 each reduces HG-induced ROS, caspase-3 activation and DNA damage demonstrating that TXNIP up-regulation under chronic hyperglycemia is critically involved in cellular oxidative stress, DNA damage and retinal pericyte apoptosis. Thus, TXNIP represents a novel gene and drug target to prevent pericyte loss and progression of DR.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23353834      PMCID: PMC5658006          DOI: 10.1016/j.yexcr.2013.01.012

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  58 in total

1.  Induction of endoplasmic reticulum stress in retinal pericytes by glucose deprivation.

Authors:  Kengo Ikesugi; Michael L Mulhern; Christian J Madson; Ken-Ichi Hosoya; Tetsuya Terasaki; Peter F Kador; Toshimichi Shinohara
Journal:  Curr Eye Res       Date:  2006-11       Impact factor: 2.424

2.  Thioredoxins 1 and 2 protect retinal ganglion cells from pharmacologically induced oxidative stress, optic nerve transection and ocular hypertension.

Authors:  Yasunari Munemasa; Jacky M K Kwong; Seok H Kim; Jae H Ahn; Joseph Caprioli; Natik Piri
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy.

Authors:  Anusha Mishra; Eric A Newman
Journal:  Glia       Date:  2010-12       Impact factor: 7.452

4.  Site-specific and redox-controlled S-nitrosation of thioredoxin.

Authors:  Katherine T Barglow; Charles G Knutson; John S Wishnok; Steven R Tannenbaum; Michael A Marletta
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-17       Impact factor: 11.205

5.  Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy.

Authors:  Pedro Geraldes; Junko Hiraoka-Yamamoto; Motonobu Matsumoto; Allen Clermont; Michael Leitges; Andre Marette; Lloyd P Aiello; Timothy S Kern; George L King
Journal:  Nat Med       Date:  2009-11-01       Impact factor: 53.440

6.  Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein.

Authors:  P Christian Schulze; Jun Yoshioka; Tomosaburo Takahashi; Zhiheng He; George L King; Richard T Lee
Journal:  J Biol Chem       Date:  2004-05-05       Impact factor: 5.157

7.  Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes.

Authors:  L Zheng; Y Du; C Miller; R A Gubitosi-Klug; T S Kern; S Ball; B A Berkowitz
Journal:  Diabetologia       Date:  2007-06-22       Impact factor: 10.122

8.  Establishment of conditionally immortalized rat retinal pericyte cell lines (TR-rPCT) and their application in a co-culture system using retinal capillary endothelial cell line (TR-iBRB2).

Authors:  Tetsu Kondo; Ken-Ichi Hosoya; Satoko Hori; Masatoshi Tomi; Sumio Ohtsuki; Hitomi Takanaga; Emi Nakashima; Hisashi Iizasa; Tomoko Asashima; Masatsugu Ueda; Masuo Obinata; Tetsuya Terasaki
Journal:  Cell Struct Funct       Date:  2003-06       Impact factor: 2.212

9.  Distinct cytoplasmic and nuclear functions of the stress induced protein DDIT3/CHOP/GADD153.

Authors:  Alexandra Jauhiainen; Christer Thomsen; Linda Strömbom; Pernilla Grundevik; Carola Andersson; Anna Danielsson; Mattias K Andersson; Olle Nerman; Linda Rörkvist; Anders Ståhlberg; Pierre Åman
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

10.  TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia: implications for diabetic retinopathy.

Authors:  Takhellambam S Devi; Icksoo Lee; Maik Hüttemann; Ashok Kumar; Kwaku D Nantwi; Lalit P Singh
Journal:  Exp Diabetes Res       Date:  2012-03-18
View more
  50 in total

1.  Verapamil Inhibits Ser202/Thr205 Phosphorylation of Tau by Blocking TXNIP/ROS/p38 MAPK Pathway.

Authors:  Mariarosa Anna Beatrice Melone; Clemente Dato; Simona Paladino; Cinzia Coppola; Claudia Trebini; Maria Teresa Giordana; Lorena Perrone
Journal:  Pharm Res       Date:  2018-02-05       Impact factor: 4.200

Review 2.  The cysteine proteome.

Authors:  Young-Mi Go; Joshua D Chandler; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2015-04-03       Impact factor: 7.376

3.  Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic Retinopathy.

Authors:  Lalit P Singh
Journal:  J Clin Exp Ophthalmol       Date:  2013-08-05

Review 4.  Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.

Authors:  Elizabeth P Moran; Zhongxiao Wang; Jing Chen; Przemyslaw Sapieha; Lois E H Smith; Jian-Xing Ma
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-29       Impact factor: 4.733

5.  Catalase activity, allelic variations in the catalase gene and risk of kidney complications in patients with type 1 diabetes.

Authors:  Kamel Mohammedi; Thiago A Patente; Naïma Bellili-Muñoz; Fathi Driss; Maria Beatriz Monteiro; Ronan Roussel; Elizabeth J Pavin; Nathalie Seta; Frédéric Fumeron; Mirela J Azevedo; Luis H Canani; Samy Hadjadj; Michel Marre; Maria Lúcia Corrêa-Giannella; Gilberto Velho
Journal:  Diabetologia       Date:  2013-09-21       Impact factor: 10.122

6.  Modes of Retinal Cell Death in Diabetic Retinopathy.

Authors:  Derrick J Feenstra; E Chepchumba Yego; Susanne Mohr
Journal:  J Clin Exp Ophthalmol       Date:  2013-10-01

Review 7.  Models of retinal diseases and their applicability in drug discovery.

Authors:  Goldis Malek; Julia Busik; Maria B Grant; Mayur Choudhary
Journal:  Expert Opin Drug Discov       Date:  2018-01-30       Impact factor: 6.098

Review 8.  Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication.

Authors:  Sanaz Nasoohi; Saifudeen Ismael; Tauheed Ishrat
Journal:  Mol Neurobiol       Date:  2018-02-27       Impact factor: 5.590

Review 9.  Mechanisms involved in the development of diabetic retinopathy induced by oxidative stress.

Authors:  David Calderón Guzman; Hugo Juárez Olguín; Ernestina Hernández García; Armando Valenzuela Peraza; Diego Zamora de la Cruz; Monica Punzo Soto
Journal:  Redox Rep       Date:  2016-07-15       Impact factor: 4.412

10.  The Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes.

Authors:  Ferhan S Siddiqi; Syamantak Majumder; Kerri Thai; Moustafa Abdalla; Pingzhao Hu; Suzanne L Advani; Kathryn E White; Bridgit B Bowskill; Giuliana Guarna; Claudia C Dos Santos; Kim A Connelly; Andrew Advani
Journal:  J Am Soc Nephrol       Date:  2015-11-03       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.